Increasing instances of substandard, falsified and counterfeit medical products continue to pose a major challenge to the global healthcare system which is already suffering from the dire impact of COVID-19. To address this issue, ASPA and Messe Frankfurt India will unite leading experts from
More
Terrassa (Barcelona): Telstar will be exhibiting the latest developments in aseptic technology
SIRIO Group’s global Nutra-Innovation Team is rapidly intensifying efforts to create new formulations in different
Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and
MONTGOMERY, Ala. and PRINCETON, N.J. and LONDON and BANGALORE, India, Aedesius Health, a division of AedesiusOne Ltd, and its biopharmaceutical
MoreCambridge, UK, Framingham, MA (USA), and Dijon, France, Abzena, a partner research organization for integrated services from discovery through to clinical
MoreHoboken, NJ, Rostock/Berlin, Germany, Based on Whole Genome Sequencing (WGS), Arcensus GmbH makes it possible to detect rare as well
More
NOTTINGHAM (UK) Quotient Sciences – a global drug development and manufacturing accelerator offering a suite of services to clients in the
More
HONG KONG, Global pandemic control is still facing enormous challenges after more than two years since the outbreak of the
MoreDean Kavanagh, Managing Director of QED Environmental Systems Ltd in the UK, has been appointed Co-Chair of the Council of
MoreRockville, Emmes, a global, full-service Clinical Research Organization dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced
MoreGlobal contract development and manufacturing organisation (CDMO), Recipharm, has today announced the acquisition of GenIbet, a Portuguese CDMO, specialising in
MoreAn IgY neutralizing antibody, which is claimed to inhibit the activity of SARS-CoV-2, the novel coronavirus that causes COVID-19, by
More
Singapore, Asia’s integrated healthcare company, Clearbridge Health Limite is pleased to announce that Labnovation Technologies, Inc.’s (“Labnovation”) COVID-19 Antigen Rapid (“ART”)
More
